rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Meredith Cook

Sr. VP, General Counsel & Sec.

Company insider

Files Form 4 as: Sr. VP, General Counsel & Sec., ANI Pharmaceuticals.

In numbers

Trades disclosed
70
Buys
0
Sells
36
Bought
$0
Sold
$1.3M
Companies
1
Companies where not an officer
0
First trade
18 Jul 2022
Last trade
13 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
ANIP ANI PharmaceuticalsOfficer · Pharmaceuticals · last 13 Oct 20260 buys · 36 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
13 Oct 2026filed 13 Oct 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$37K500 at $73.59filing
14 Sep 2026filed 14 Sep 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$35K500 at $70.79filing
14 Sep 2026filed 14 Sep 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$35K500 at $70.79filing
13 Aug 2026filed 13 Aug 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$38K500 at $75.48filing
13 Aug 2026filed 13 Aug 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$38K500 at $75.48filing
18 Jul 2026filed 21 Jul 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$195K2,466 at $79.20filing
18 Jul 2026filed 21 Jul 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$195K2,466 at $79.20filing
13 Jul 2026filed 14 Jul 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$41K500 at $81.84filing
13 Jul 2026filed 14 Jul 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$41K500 at $81.84filing
12 Jun 2026filed 15 Jun 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$41K500 at $82.03filing
12 Jun 2026filed 15 Jun 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$41K500 at $82.03filing
13 May 2026filed 13 May 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$39K500 at $78.16filing
13 May 2026filed 13 May 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$39K500 at $78.16filing
13 Apr 2026filed 13 Apr 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$39K500 at $77.95filing
13 Apr 2026filed 13 Apr 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$39K500 at $77.95filing
13 Mar 2026filed 13 Mar 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$36K500 at $72.62filing
13 Mar 2026filed 13 Mar 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Sold$36K500 at $72.62filing
28 Feb 2026filed 2 Mar 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$115K1,555 at $73.90filing
28 Feb 2026filed 2 Mar 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Code F$115K1,555 at $73.90filing
26 Feb 2026filed 2 Mar 2026ANIP ANI PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A$1.1M13,895 at $77.15filing

Sectors

Health Care36

Buys in green, sells in red, by the company’s sector.

Related people

Nikhil LalwaniPresident & CEO · President & CEO at Ani Pharmaceuticals, filing Form 4 there in the last year
Stephen P. CareySVP & CFO · SVP & CFO at Ani Pharmaceuticals, filing Form 4 there in the last year
Jeanne ThomaDirector · Director at Ani Pharmaceuticals, filing Form 4 there in the last year
Henry O. GosebruchDirector · Director at Ani Pharmaceuticals, filing Form 4 there in the last year
Ori GutwergSVP, Generics · SVP, Generics at Ani Pharmaceuticals, filing Form 4 there in the last year